Dr. Segarra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Clarkson Ave
# 1228
Brooklyn, NY 11203Phone+1 718-245-3318Fax+1 718-245-4799
Summary
- Dr. Theodore Segarra is an intensivist in West Islip, NY and is affiliated with Good Samaritan Hospital Medical Center. He received his medical degree from SUNY Downstate Medical Center College of Medicine / Kings County Hospital, where he later completed a combined residency program in Emergency Medicine and Internal Medicine, as well as a fellowship program in Critical Care Medicine. He currently specializes in critical care medicine and serves as the Associate Director of the Cardiothoracic ICU, and has been practicing in this field for 1 year.
Education & Training
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine/Emergency Medicine, 2015 - 2020
State University of New York Downstate Medical Center College of MedicineClass of 2015
Certifications & Licensure
NY State Medical License 2021 - 2026- American Board of Emergency Medicine Emergency Medicine
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
Publications & Presentations
PubMed
- 69 citationsIntravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infectionPedro M. M. Mesquita, Rachna Rastogi, Theodore J. Segarra, Ryan S. Teller, N. Merna Torres
The Journal of Antimicrobial Chemotherapy. 2012-07-01 - 87 citationsGriffithsin Protects Mice from Genital Herpes by Preventing Cell-to-Cell SpreadBriana G. Nixon, Martha Stefanidou, Pedro M. M. Mesquita, Esra Fakioglu, Theodore J. Segarra
Journal of Virology. 2013-06-01 - 25 citationsBridging the Gap between Preclinical and Clinical Microbicide Trials: Blind Evaluation of Candidate Gels in Murine Models of Efficacy and SafetyTheodore J. Segarra, Esra Fakioglu, Natalia Cheshenko, Sarah S. Wilson, Pedro M. M. Mesquita
Plos One. 2011-11-11
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
